Cargando…
Management of sulfonylurea‐treated monogenic diabetes in pregnancy: implications of placental glibenclamide transfer
The optimum treatment for HNF1A/HNF4A maturity‐onset diabetes of the young and ATP‐sensitive potassium (K(ATP)) channel neonatal diabetes, outside pregnancy, is sulfonylureas, but there is little evidence regarding the most appropriate treatment during pregnancy. Glibenclamide has been widely used i...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612398/ https://www.ncbi.nlm.nih.gov/pubmed/28556992 http://dx.doi.org/10.1111/dme.13388 |